Open Beta
MetriLume

US marketsCLS

SEC-sourced researchBeta

CLS

CELESTICA INC

Company comparison ↗

Data passport

CIK
0001030894
Exchange
NYSE
Business activity
— · SIC 3672
Financial inputs
6/6
Filing date
Oct 1, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 7,961,000,000.0000 USD; December 2024: 9,646,000,000.0000 USD; December 2025: 12,390,900,000.0000 USD12.4B USD0 USD0December 2023December 2024December 2025
CLS · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20237,961,000,000.0000Feb 27, 2026
December 20249,646,000,000.0000Feb 27, 2026
December 202512,390,900,000.0000Feb 27, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202512,390,900,000.0000832,500,000.0000659,500,000.00007,213,100,000.00004,996,800,000.0000Feb 27, 2026
December 20249,646,000,000.0000428,000,000.0000473,900,000.00005,988,200,000.00004,092,200,000.0000Feb 27, 2026
December 20237,961,000,000.0000244,400,000.0000326,200,000.0000——Feb 27, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$12.39BDecember 2025Feb 27, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$9.65BDecember 2024Feb 27, 202610-K
Net incomeNetIncomeLoss$832.5MDecember 2025Feb 27, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$659.5MDecember 2025Feb 27, 202610-K
Total assetsAssets$7.21BDecember 2025Feb 27, 202610-K
Total liabilitiesLiabilities$5BDecember 2025Feb 27, 202610-K

New filings

Explore methodology ↗